As you may be informed, the ESICM Transfusion Guideline Task Force is currently preparing the first international anticoagulation reversal guideline for the intensive care unit (ICU) setting. In succession of the TRACE-1 and TRACE-2 survey in which we studied transfusion practices in the (non-)bleeding ICU patient, we now aim to examine anticoagulation reversal practices in this population (ROTATION survey).
If you’ve already taken the time to circulate and/or complete the survey, we extend our sincere gratitude!
This survey can be answered until January 2024: https://www.esicm.org/research/surveys/#ROTATION
Survey: The aim of the survey is to collect baseline measurements of international policies and practices of anticoagulation reversal used in the ICU, including different types of anticoagulants, thresholds per diagnostic tests, choices of types anticoagulation reversal drugs and blood products. This research could be helpful to monitor and guide future changes in anticoagulation reversal practices in the ICU (i.e. response to new international guidelines) or to identify knowledge gaps.
Endorsement: This study is currently endorsed by the ESICM Research Committee, and other ICU societies such as SIAARTI (Italy) and Intensive Care Society (UK).
Target group: intensivists, intensivist in training and non-intensivists specialists attending in the intensive care medicine.
Anonymized: Rest assured, all responses will be anonymized and reported in aggregate, and we’re committed to sharing the findings with participating societies. Completing this survey will take approximately 20 minutes.
